Horizon 2020 research project ALTERNATIVE develops an innovative platform for assessing the cardiotoxicity of chemicals. The novel platform will enable regulators and industry to identify, quantify and prevent cardiotoxic co-exposures to industrial chemicals and pharmaceuticals in a cost-effective way.
ALTERNATIVE at Kick-Off Meeting of European Green Deal Chemicals’ Cluster
On 3rd February, a kick-off cluster event was organized by European Research Agency for the projects under work programme topic “Building a low-carbon, climate resilient future: Research and innovation in […]
Read more
ALTERNATIVE presentation at PARERE workshop on regulatory requirements for cardiotoxicity data
On 21st December 2021, a joint workshop of the Austrian and Belgian networks for the ‘Preliminary Assessment of Regulatory Relevance of Alternative methods and approaches (PARERE)’ was organized online. The […]
Read more
Training session on Adverse Outcome Pathways with OECD experts
Adverse Outcome Pathways (AOPs) are a key deliverable for the regulatory uptake of the ALTERNATIVE project. But what do AOPs exactly represent? Which purpose do they serve? And how are […]
Read more
Productive kick-off meeting of ALTERNATIVE advisory board
On 17th December, the kick-off meeting of the ALTERNATIVE advisory board took place online. The purpose of the advisory board is to provide advice on the direction and implementation of […]
Read more
ALTERNATIVE project builds platform for detecting the cardiotoxicity of chemicals
Turin, 20 October 2021. On 1st October, the three-year Horizon 2020 project ALTERNATIVE (environmentAL Toxicity chEmical mixtuRes through aN innovative platform based on aged cardiac tissue model) started its work. […]
Read more
